STEM CELLS AND ADVANCED THERAPIES
Instituto de Salud Carlos III
Madrid, EspañaPublications in collaboration with researchers from Instituto de Salud Carlos III (7)
2022
-
Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals
Frontiers in Genetics, Vol. 13
2021
-
Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)
Scientific Reports
-
Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications
Scientific Reports, Vol. 11, Núm. 1
2020
-
Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients
European Journal of Human Genetics, Vol. 28, Núm. 4, pp. 469-479
2019
-
Suitability and limitations of mesenchymal stem cells to elucidate human bone illness
World Journal of Stem Cells, Vol. 11, Núm. 9, pp. 578-593
2018
-
Missense Mutations of the Pro65 Residue of PCGF2 Cause a Recognizable Syndrome Associated with Craniofacial, Neurological, Cardiovascular, and Skeletal Features
American Journal of Human Genetics, Vol. 103, Núm. 5, pp. 786-793
-
Parental mosaicism in PAX6 causes intra-familial variability: Implications for genetic counseling of congenital aniridia and microphthalmia
Frontiers in Genetics, Vol. 9, Núm. OCT